These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 39072182)

  • 1. Weiwei Decoction alleviates gastric intestinal metaplasia through the olfactomedin 4/nucleotide-binding oligomerization domain 1/caudal-type homeobox gene 2 signaling pathway.
    Zhou DS; Zhang WJ; Song SY; Hong XX; Yang WQ; Li JJ; Xu JQ; Kang JY; Cai TT; Xu YF; Guo SJ; Pan HF; Li HW
    World J Gastrointest Oncol; 2024 Jul; 16(7):3211-3229. PubMed ID: 39072182
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy and potential therapeutic mechanism of Weiwei decoction on Spasmolytic polypeptide-expressing metaplasia in Helicobacter pylori-infected and Atp4a-knockout mice.
    Hong X; Li H; Lin Y; Luo L; Xu W; Kang J; Li J; Huang B; Xu Y; Pan H; Guo S
    J Ethnopharmacol; 2024 Jan; 319(Pt 1):117062. PubMed ID: 37598768
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cdx2 Expression and Intestinal Metaplasia Induced by H. pylori Infection of Gastric Cells Is Regulated by NOD1-Mediated Innate Immune Responses.
    Asano N; Imatani A; Watanabe T; Fushiya J; Kondo Y; Jin X; Ara N; Uno K; Iijima K; Koike T; Strober W; Shimosegawa T
    Cancer Res; 2016 Mar; 76(5):1135-45. PubMed ID: 26759244
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Study on the Mechanism of Olfactomedin 4-shRNA Plasmid Chitosan Magnetic Nanoparticles in Intestinal Metaplasia of Chronic Atrophic Gastritis.
    Li H; Li J; Li P; Zhang W; Yang W; Xu Y; Kang J; Zhang J; Wu Y; Pan H; Guo S
    J Nanosci Nanotechnol; 2020 Dec; 20(12):7324-7332. PubMed ID: 32711597
    [TBL] [Abstract][Full Text] [Related]  

  • 5. OLFM4 promotes the progression of intestinal metaplasia through activation of the MYH9/GSK3β/β-catenin pathway.
    Wei H; Li W; Zeng L; Ding N; Li K; Yu H; Jiang F; Yin H; Xia Y; Deng C; Cai N; Chen X; Gu L; Chen H; Zhang F; He Y; Li J; Zhang C
    Mol Cancer; 2024 Jun; 23(1):124. PubMed ID: 38849840
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Olfactomedin-related proteins 4 (OLFM4) expression is involved in early gastric carcinogenesis and of prognostic significance in advanced gastric cancer.
    Jang BG; Lee BL; Kim WH
    Virchows Arch; 2015 Sep; 467(3):285-94. PubMed ID: 26070873
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Olfactomedin 4 down-regulates innate immunity against Helicobacter pylori infection.
    Liu W; Yan M; Liu Y; Wang R; Li C; Deng C; Singh A; Coleman WG; Rodgers GP
    Proc Natl Acad Sci U S A; 2010 Jun; 107(24):11056-61. PubMed ID: 20534456
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SOX2 Inhibition Promotes Promoter Demethylation of CDX2 to Facilitate Gastric Intestinal Metaplasia.
    Niu H; Jia Y; Li T; Su B
    Dig Dis Sci; 2017 Jan; 62(1):124-132. PubMed ID: 27913994
    [TBL] [Abstract][Full Text] [Related]  

  • 9. OCT-1 is over-expressed in intestinal metaplasia and intestinal gastric carcinomas and binds to, but does not transactivate, CDX2 in gastric cells.
    Almeida R; Almeida J; Shoshkes M; Mendes N; Mesquita P; Silva E; Van Seuningen I; Reis CA; Santos-Silva F; David L
    J Pathol; 2005 Dec; 207(4):396-401. PubMed ID: 16278805
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Down-regulation of a gastric transcription factor, Sox2, and ectopic expression of intestinal homeobox genes, Cdx1 and Cdx2: inverse correlation during progression from gastric/intestinal-mixed to complete intestinal metaplasia.
    Tsukamoto T; Inada K; Tanaka H; Mizoshita T; Mihara M; Ushijima T; Yamamura Y; Nakamura S; Tatematsu M
    J Cancer Res Clin Oncol; 2004 Mar; 130(3):135-45. PubMed ID: 14655050
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activation of FXR promotes intestinal metaplasia of gastric cells via SHP-dependent upregulation of the expression of CDX2.
    Zhou H; Ni Z; Li T; Su L; Zhang L; Liu N; Shi Y
    Oncol Lett; 2018 May; 15(5):7617-7624. PubMed ID: 29849798
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Expression of intestine-specific transcription factor CDX2 in different subtypes of intestinal metaplasia and gastric carcinoma].
    Liu GS; Gong J; Cheng P; Zhang J; Chang Y; Qiang L
    Ai Zheng; 2006 Feb; 25(2):185-9. PubMed ID: 16480583
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Wei-fu-chun tablet halted gastric intestinal metaplasia and dysplasia associated with inflammation by regulating the NF-κB pathway.
    Xie D; Wu C; Wang D; Nisma Lena BA; Liu N; Ye G; Sun M
    J Ethnopharmacol; 2024 Jan; 318(Pt B):117020. PubMed ID: 37567428
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Olfactomedin 4 expression and functions in innate immunity, inflammation, and cancer.
    Liu W; Rodgers GP
    Cancer Metastasis Rev; 2016 Jun; 35(2):201-12. PubMed ID: 27178440
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of Cdx1 and Cdx2 mRNAs and relevance of this expression to differentiation in human gastrointestinal mucosa--with special emphasis on participation in intestinal metaplasia of the human stomach.
    Mizoshita T; Inada K; Tsukamoto T; Kodera Y; Yamamura Y; Hirai T; Kato T; Joh T; Itoh M; Tatematsu M
    Gastric Cancer; 2001; 4(4):185-91. PubMed ID: 11846061
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of intestine-specific transcription factors, CDX1 and CDX2, in intestinal metaplasia and gastric carcinomas.
    Almeida R; Silva E; Santos-Silva F; Silberg DG; Wang J; De Bolós C; David L
    J Pathol; 2003 Jan; 199(1):36-40. PubMed ID: 12474224
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SOX2 interferes with the function of CDX2 in bile acid-induced gastric intestinal metaplasia.
    Yuan T; Ni Z; Han C; Min Y; Sun N; Liu C; Shi M; Lu W; Wang N; Du F; Wu Q; Xie N; Shi Y
    Cancer Cell Int; 2019; 19():24. PubMed ID: 30733645
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MicroRNA-92a-1-5p increases CDX2 by targeting FOXD1 in bile acids-induced gastric intestinal metaplasia.
    Li T; Guo H; Li H; Jiang Y; Zhuang K; Lei C; Wu J; Zhou H; Zhu R; Zhao X; Lu Y; Shi C; Nie Y; Wu K; Yuan Z; Fan DM; Shi Y
    Gut; 2019 Oct; 68(10):1751-1763. PubMed ID: 30635407
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of CDX2 and villin in gastric cardiac intestinal metaplasia and the relation with gastric cardiac carcinogenesis.
    Xiao ZY; Ru Y; Sun JT; Gao SG; Wang YF; Wang LD; Feng XS
    Asian Pac J Cancer Prev; 2012; 13(1):247-50. PubMed ID: 22502678
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bile acids promote gastric intestinal metaplasia by upregulating CDX2 and MUC2 expression via the FXR/NF-κB signalling pathway.
    Yu JH; Zheng JB; Qi J; Yang K; Wu YH; Wang K; Wang CB; Sun XJ
    Int J Oncol; 2019 Mar; 54(3):879-892. PubMed ID: 30747230
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.